State Street’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $64.1K | Hold |
106,735
| – | – | ﹤0.01% | 4054 |
|
|
2025
Q1 | $28.8K | Hold |
106,735
| – | – | ﹤0.01% | 4163 |
|
|
2024
Q4 | $55.5K | Buy |
106,735
+7,500
| +8% | +$3.9K | ﹤0.01% | 4094 |
|
|
2024
Q3 | $322K | Sell |
99,235
-6,644
| -6% | -$21.5K | ﹤0.01% | 3693 |
|
|
2024
Q2 | $318K | Sell |
105,879
-5,250
| -5% | -$15.8K | ﹤0.01% | 3678 |
|
|
2024
Q1 | $517K | Sell |
111,129
-4,100
| -4% | -$19.1K | ﹤0.01% | 3639 |
|
|
2023
Q4 | $477K | Hold |
115,229
| – | – | ﹤0.01% | 3651 |
|
|
2023
Q3 | $346K | Sell |
115,229
-14,200
| -11% | -$42.6K | ﹤0.01% | 3763 |
|
|
2023
Q2 | $318K | Sell |
129,429
-421,667
| -77% | -$1.04M | ﹤0.01% | 3846 |
|
|
2023
Q1 | $1.25M | Buy |
551,096
+55,363
| +11% | +$125K | ﹤0.01% | 3464 |
|
|
2022
Q4 | $1.73M | Sell |
495,733
-94,401
| -16% | -$329K | ﹤0.01% | 3420 |
|
|
2022
Q3 | $21.8M | Sell |
590,134
-11,051
| -2% | -$409K | ﹤0.01% | 2153 |
|
|
2022
Q2 | $11.4M | Buy |
601,185
+155,621
| +35% | +$2.96M | ﹤0.01% | 2641 |
|
|
2022
Q1 | $12M | Buy |
445,564
+122,163
| +38% | +$3.3M | ﹤0.01% | 2719 |
|
|
2021
Q4 | $7.29M | Sell |
323,401
-2,470
| -0.8% | -$55.6K | ﹤0.01% | 3068 |
|
|
2021
Q3 | $8.54M | Buy |
325,871
+15,707
| +5% | +$412K | ﹤0.01% | 2974 |
|
|
2021
Q2 | $9.93M | Buy |
310,164
+19,579
| +7% | +$627K | ﹤0.01% | 2925 |
|
|
2021
Q1 | $10.2M | Sell |
290,585
-13,874
| -5% | -$488K | ﹤0.01% | 2732 |
|
|
2020
Q4 | $9.76M | Buy |
304,459
+2,138
| +0.7% | +$68.6K | ﹤0.01% | 2642 |
|
|
2020
Q3 | $11.4M | Buy |
302,321
+17,550
| +6% | +$660K | ﹤0.01% | 2372 |
|
|
2020
Q2 | $12.7M | Buy |
284,771
+276,371
| +3,290% | +$12.4M | ﹤0.01% | 2286 |
|
|
2020
Q1 | $287K | Buy |
+8,400
| New | +$287K | ﹤0.01% | 3532 |
|